<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20031101//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3378692</article-id><article-id pub-id-type="pmid">22723975</article-id><article-id pub-id-type="publisher-id">PONE-D-12-04153</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0039247</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Genetics</subject><subj-group><subject>Population Genetics</subject><subj-group><subject>Genetic Polymorphism</subject></subj-group></subj-group></subj-group><subj-group><subject>Immunology</subject><subj-group><subject>Autoimmunity</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical Genetics</subject><subj-group><subject>Genetic Testing</subject></subj-group></subj-group><subj-group><subject>Clinical Immunology</subject><subj-group><subject>Immunity</subject><subj-group><subject>Immunity to Infections</subject></subj-group></subj-group><subj-group><subject>Allergy and Hypersensitivity</subject></subj-group></subj-group><subj-group><subject>Otorhinolaryngology</subject><subj-group><subject>Rhinology</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Polymorphisms in RYBP and AOAH Genes Are Associated with Chronic Rhinosinusitis in a Chinese Population: A Replication Study</article-title><alt-title alt-title-type="running-head">SNPs in RYBP and AOAH and Chronic Rhinosinusitis</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yuan</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Endam</surname><given-names>Leandra Mfuna</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Filali-Mouhim</surname><given-names>Abdelali</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Liping</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Desrosiers</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>&#x0002a;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Demin</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>&#x0002a;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Luo</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>&#x0002a;</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, People&#x02019;s Republic of China</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Key Laboratory Otolaryngology Head and Neck Surgery, Ministry of Education of China, Beijing Institute of Otolaryngology, Beijing, People&#x02019;s Republic of China</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Department of Otolaryngology, Centre de Recherche du Centre Hospitalier de l&#x02019;Universit&#x000e9; de Montr&#x000e9;al (CRCHUM), Montreal, Quebec, Canada</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Department of Otolaryngology-Head and Neck Surgery, Montreal General Hospital, McGill University, Montreal, Quebec, Canada</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Carvalho</surname><given-names>Luzia Helena</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Centro de Pesquisa Rene Rachou/Funda&#x000e7;&#x000e3;o Oswaldo Cruz (Fiocruz-Minas), Brazil</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>dr.luozhang@gmail.com</email> (LZ); <email>handm@trhos.com</email> (DH); <email>desrosiers_martin@hotmail.com</email> (MD)</corresp><fn fn-type="con"><p>Conceived and designed the experiments: YZ MD L. Zhang. Performed the experiments: YZ LE AF MD L. Zhao. Analyzed the data: YZ LE AF L. Zhao MD DH L. Zhang. Contributed reagents/materials/analysis tools: YZ LE AF L. Zhao MD DH L. Zhang. Wrote the paper: YZ MD L. Zhang.</p></fn></author-notes><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>19</day><month>6</month><year>2012</year></pub-date><volume>7</volume><issue>6</issue><elocation-id>e39247</elocation-id><history><date date-type="received"><day>9</day><month>2</month><year>2012</year></date><date date-type="accepted"><day>18</day><month>5</month><year>2012</year></date></history><permissions><copyright-statement>Zhang et al.</copyright-statement><copyright-year>2012</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Background</title><p>The development of CRS is believed to be the result of combined interactions between the genetic background of the affected subject and environmental factors.</p></sec><sec><title>Objectives</title><p>To replicate and extend our recent findings from genetic association studies in chronic rhinosinusitis (CRS) performed in a Canadian Caucasian population in a Chinese population.</p></sec><sec><title>Methods</title><p>In a case-control replication study, DNA samples were obtained from CRS with (n&#x0200a;=&#x0200a;306; CRSwNP) and without (n&#x0200a;=&#x0200a;332; CRSsNP) nasal polyps, and controls (n&#x0200a;=&#x0200a;315) in a Chinese population. A total of forty-nine single nucleotide polymorphisms (SNPs) selected from previous identified SNPs associated with CRS in Canadian population, and SNPs from the CHB HapMap dataset were individually genotyped.</p></sec><sec><title>Results</title><p>We identified two SNPs respectively in RYBP (rs4532099, p&#x0200a;=&#x0200a;2.15E&#x02013;06, OR&#x0200a;=&#x0200a;2.59) and AOAH (rs4504543, p&#x0200a;=&#x0200a;0.0001152, OR&#x0200a;=&#x0200a;0.58) significantly associated with whole CRS cohort. Subgroup analysis for the presence of nasal polyps (CRSwNP and CRSsNP) displayed significant association in CRSwNP cohorts regarding to one SNP in RYBP (<italic>P</italic>&#x0200a;=&#x0200a;3.24<sup>E</sup>&#x02013;006, OR&#x0200a;=&#x0200a;2.76). Evidence of association in the CRSsNP groups in terms of 2 SNPs (AOAH_rs4504543 and RYBP_rs4532099) was detected as well. Stratifying analysis by gender demonstrated that none of the selected SNPs were associated with CRSwNP as well as CRSsNP. Meanwhile 3 SNPs (IL1A_rs17561, P&#x0200a;=&#x0200a;0.005778; IL1A_rs1800587, P&#x0200a;=&#x0200a;0.009561; IRAK4_rs4251513, P&#x0200a;=&#x0200a;0.03837) were associated with serum total IgE level.</p></sec><sec><title>Conclusions</title><p>These genes are biologically plausible, with roles in regulation of transcription (RYBP) and inflammatory response (AOAH). The present data suggests the potential common genetic basis in the development of CRS in Chinese and Caucasian population.</p></sec></abstract><counts><page-count count="8"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Chronic rhinosinusitis (CRS) is a common inflammatory disorder of the sinus and paranasal sinus mucosa with a highly heterogeneous pathogenesis. Because of its negative impact on patients&#x02019; quality of life and the concomitant increasing social economic burden, CRS has become a global health problem <xref rid="pone.0039247-Tewfik1" ref-type="bibr">[1]</xref>. The development of CRS is believed to be the result of combinations between the genetic background of the affected subject and environmental factors <xref rid="pone.0039247-Tewfik1" ref-type="bibr">[1]</xref>, <xref rid="pone.0039247-MfunaEndam1" ref-type="bibr">[2]</xref>. However, there is still no clear answer as to their exact contributions to the process and the mechanisms of pathogenesis of CRS.</p><p>A genetic basis to sinusitis is strongly suggested by clinical and experimental evidence <xref rid="pone.0039247-Castano1" ref-type="bibr">[3]</xref>&#x02013;<xref rid="pone.0039247-Zhang1" ref-type="bibr">[10]</xref>. In humans, genetic disorder such as cystic fibrosis and primary ciliary dyskinesia <xref rid="pone.0039247-Lee1" ref-type="bibr">[11]</xref> are frequently associated with development of sinusitis in knockout mouse models, deletion of several genes leads to development of sinusitis.</p><p>It has been demonstrated that single nucleotide polymorphisms (SNPs) in several genes are associated with CRS <xref rid="pone.0039247-Castano1" ref-type="bibr">[3]</xref>&#x02013;<xref rid="pone.0039247-Zhang1" ref-type="bibr">[10]</xref> These are biologically plausible, with roles in regulation of transcription (Ring1A and YY1 binding protein, RYBP) <xref rid="pone.0039247-Bejarano1" ref-type="bibr">[12]</xref>_ENREF_13, inflammatory response (acyloxyacyl hydroxylase, AOAH) <xref rid="pone.0039247-Barnes1" ref-type="bibr">[13]</xref> and innate immune response (IL1RL1 <xref rid="pone.0039247-Castano2" ref-type="bibr">[5]</xref>, <xref rid="pone.0039247-Savenije1" ref-type="bibr">[14]</xref> and interleukin-1 receptor-associated kinase 4 (IRAK4) <xref rid="pone.0039247-Tewfik2" ref-type="bibr">[6]</xref>, <xref rid="pone.0039247-Kim1" ref-type="bibr">[15]</xref>), are associated with chronic rhinosinusitis (CRS) in a Canadian Caucasian population <xref rid="pone.0039247-Bosse1" ref-type="bibr">[16]</xref>. Replication of results of a genetic disease association study in independent samples has emerged as a standard for demonstrating the relevance of a candidate gene for a complex trait.</p><p>Given the evidence above, genetic backgroung plays potencial roles in the development of CRS and we hypothesized genes which were demontrated as susceptible genes for CRS in Caucasian population also exerted effects in Chinese cohort. Therefore, the aim of this study was to replicate polymorphisms in the genes performed in Canadian Caucasian population previously are associated with the Chinese population. A population-based case-control association analysis was used to assess the risk of CRS conferred by SNPs in the candidate genes in our Han Chinese cohort.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Study Subjects</title><p>306 CRS with nasal polyps (CRSwNP subjects) (180 males and 126 females) and 332 individuals affected with CRS without nasal polyps (CRSsNP) (190 males and 142 females) were prospectively recruited from the rhinology ward of Beijing Tongren Hospital between February 2008 to July 2009. A total of 315 healthy controls, of which 146 (46.3&#x00025;) were female, were recruited as well. All the subjects were of Chinese Han ethnic origin and all from the north region of China. The study was approved by the Beijing Tongren Hospital Ethics Committee, and written informed consent was obtained from all participants.</p><p>Diagnosis of CRSwNP and CRSsNP was based on American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) 2004 guidelines <xref rid="pone.0039247-Meltzer1" ref-type="bibr">[17]</xref>, based on assement by a single ENT doctor specialized in sinus diseases. All the CRS cases recruited in present study were unresponsive to all forms of medical therapies such as topical or intranasal corticosteroid and long term-low dose antibiotic or presented persistent signs/symptoms of CRS despite previous endoscopic sinus surgery (ESS). Patients were interviewed by trained personnel, and a standardized questionnaire was used to obtain items including demographic variables and personal and familial antecedents of allergies. Patients also underwent a standard set of laboratory tests that included measurements of total IgE to assess allergic status. Controls were recruited following two strategies: either spouses or non-blood relatives living in the same household and individuals recruited from a geographic area similar to that of CRS patients. The only attempt at matching subjects and control is their geographical location to minimize differences secondary to differences in potential environmental exposures. Nevertheless, a standardized questionnaire assessing age, sex and ethnic origin (but not smoking, history of atopy or physician diagnosed asthma) was obtained for controls. Moreover, all the controls showed negative of serum phadiatop determination.</p></sec><sec id="s2b"><title>SNP Selection</title><p>A total of forty-one single nucleotide polymorphisms (SNPs) selected from previous identified associated with CRS in Canadian population <xref rid="pone.0039247-Castano1" ref-type="bibr">[3]</xref>, <xref rid="pone.0039247-Castano2" ref-type="bibr">[5]</xref>&#x02013;<xref rid="pone.0039247-MfunaEndam2" ref-type="bibr">[7]</xref>, <xref rid="pone.0039247-Kilty1" ref-type="bibr">[9]</xref>, <xref rid="pone.0039247-Zhang1" ref-type="bibr">[10]</xref>, <xref rid="pone.0039247-Bosse1" ref-type="bibr">[16]</xref>, <xref rid="pone.0039247-Endam1" ref-type="bibr">[18]</xref>, <xref rid="pone.0039247-Cormier1" ref-type="bibr">[19]</xref> were choose for genotying (<xref ref-type="table" rid="pone-0039247-t001">Table 1</xref>). In addition, SNPs in IRAK4 gene from the CHB HapMap dataset were also individually genotyped. Briefly, the International Haplotype Mapping (HapMap) (<ext-link ext-link-type="uri" xlink:href="http://www.hapmap.org">www.hapmap.org</ext-link>) SNP databases were used to select SNPs in the IRAK4 gene region. The screened region was extended 10 kilobases upstream of the annotated transcription start site and downstream at the end of the last IRAK4 exon. The SNPs were selected to extract the most genetic information based on CHB haplotype data using the HAPMAP database (Hapmap Data Rel 27 Phase II&#x0002b;III, Feb09) <xref rid="pone.0039247-1" ref-type="bibr">[20]</xref>. From this dataset, 34 SNPs in IRAK4 gene region were selected using a pairwise tagging algorithm implemented in Haploview version 4.1 program <xref rid="pone.0039247-Barrett1" ref-type="bibr">[21]</xref>. In addition, when we set Hardy-Weinberg p value cutoff, minor allele frequency and r2 thresholds at 0.01, 0.05 and 0.8, respectively, the LD pattern for IRAK4 gene in our population showed strong LD in several groups of SNPs, indicating that the SNPs in each group represent a common region (<xref ref-type="fig" rid="pone-0039247-g001">Figure 1</xref>). Consequently, we choose 10 SNPs including rs4251513, rs1461567, rs3794262, rs4251481, rs4251540, rs4251569, rs6582484, rs4251431, rs1870765 and rs12302873 to represent the entire 34 loci for eventual genotyping and the former two SNPs were composed in the selected SNPs from the previous identified associated with CRS in Canadian population. Therefore, 49 SNPs constituted the selection set to be genotyped in our patient and controls eventually.</p><table-wrap id="pone-0039247-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0039247.t001</object-id><label>Table 1</label><caption><title>SNPs selected from previous identified associated with CRS in Canadian population.</title></caption><alternatives><graphic id="pone-0039247-t001-1" xlink:href="pone.0039247.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Chromosome</td><td align="left" rowspan="1" colspan="1">Gene</td><td align="left" rowspan="1" colspan="1">SNP</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">PARS2</td><td align="left" rowspan="1" colspan="1">rs2873551</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">IL22RA1</td><td align="left" rowspan="1" colspan="1">rs4292900; rs4648936; rs16829225</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TNFRSF1B</td><td align="left" rowspan="1" colspan="1">rs235214; rs496888; rs652625; rs7550488</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">TRIP12</td><td align="left" rowspan="1" colspan="1">rs1035833</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">IL1RL1</td><td align="left" rowspan="1" colspan="1">rs13431828; rs10204137</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">IL1A</td><td align="left" rowspan="1" colspan="1">rs17561; rs2856838; rs2048874; rs1800587</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">FAM79B</td><td align="left" rowspan="1" colspan="1">rs13059863</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RYBP</td><td align="left" rowspan="1" colspan="1">rs4532099</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">TSLP</td><td align="left" rowspan="1" colspan="1">rs3806932;rs2289276</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">LAMA2</td><td align="left" rowspan="1" colspan="1">rs2571584</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TNFAIP3</td><td align="left" rowspan="1" colspan="1">rs3757173; rs5029938</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">LAMB1</td><td align="left" rowspan="1" colspan="1">rs4727695</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AOAH</td><td align="left" rowspan="1" colspan="1">rs4504543</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">MET</td><td align="left" rowspan="1" colspan="1">rs38850</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">RAC1</td><td align="left" rowspan="1" colspan="1">rs836479</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CACNA2D1</td><td align="left" rowspan="1" colspan="1">rs6972720</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">KIAA1456</td><td align="left" rowspan="1" colspan="1">rs11779957</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">MSRA</td><td align="left" rowspan="1" colspan="1">rs7001821</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">MUSK</td><td align="left" rowspan="1" colspan="1">rs10817091</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">PDGFD</td><td align="left" rowspan="1" colspan="1">rs12574463</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">NOS1</td><td align="left" rowspan="1" colspan="1">rs1483757</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">NAV3</td><td align="left" rowspan="1" colspan="1">rs1726427</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">IRAK4</td><td align="left" rowspan="1" colspan="1">rs4251559; rs4251513; rs146567</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">SERPINA1</td><td align="left" rowspan="1" colspan="1">rs1243168; rs4900229</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">UBE3A</td><td align="left" rowspan="1" colspan="1">rs1557871</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">SLC13A3</td><td align="left" rowspan="1" colspan="1">rs393990</td></tr><tr><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">CACNA1I</td><td align="left" rowspan="1" colspan="1">rs3788568</td></tr></tbody></table></alternatives></table-wrap><fig id="pone-0039247-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0039247.g001</object-id><label>Figure 1</label><caption><title>Linkage Dysequilibrium (LD) plot for IRAK4.</title><p>The LD plots were generated by Haploview 4.1. The white horizontal bar below the info track illustrates the location of SNPs on a physical scale. The shade of squares illustrates the strength of pairwise r2 values on a black and white scale where black indicates perfect LD (r2&#x0200a;=&#x0200a;1.00) and white indicates perfect equilibrium (r2&#x0200a;=&#x0200a;0). The r2 LD value is also indicated within each square. Failed SNP and SNPs not in Hardy-Weinberg equilibrium or with low minor allele frequency are not illustrated.</p></caption><graphic xlink:href="pone.0039247.g001"/></fig></sec><sec id="s2c"><title>Genotyping</title><p>DNA was collected in EDTA-treated tubes and isolated from peripheral blood leukocytes, using the DNA Isolation Kit for Mammalian Blood (Roche, Indianapolis, USA). Isolated DNA from blood was stored at 4&#x000b0;C prior to use. To reduce genotyping cost, the majority of the selected SNPs were genotyped by the MassArray system (Sequenom) with primers and probes (<xref ref-type="table" rid="pone-0039247-t002">Table 2</xref>) as described. One SNP (rs12302873) which was evaluated by preliminary test unsuitable to be genotyped through MassArray approach were identified by direct sequencing of PCR products of genomic DNA (<xref ref-type="table" rid="pone-0039247-t003">Table 3</xref>). Genotyping was performed without knowledge of the case or control status. A 10&#x00025; random sample was tested in duplicate by different persons, and the reproducibility was 100&#x00025;.</p><table-wrap id="pone-0039247-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0039247.t002</object-id><label>Table 2</label><caption><title>Details of the primers used in the screening of SNPs by MassArray.</title></caption><alternatives><graphic id="pone-0039247-t002-2" xlink:href="pone.0039247.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Gene</td><td align="left" rowspan="1" colspan="1">SNP</td><td align="left" rowspan="1" colspan="1">Primers (5&#x02032; - 3&#x02032;)</td><td align="left" rowspan="1" colspan="1">Extension Primers (5&#x02032; - 3&#x02032;)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">PARS2</td><td align="left" rowspan="1" colspan="1">rs2873551</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCAAACCACTTACAAGGTGGG</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CACGAGTGTCTCACCAA</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGAATTACTTGCCCTGTGTGCC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IL22RA1</td><td align="left" rowspan="1" colspan="1">rs4292900</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCCTTCCGACTTGCAGAAAAC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACTTGCAGAAAACAGCAATAG</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGACCACTTGGGATGAATCAGC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs4648936</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCTGGAGTCAGCCTAAGATTG</named-content>
</td><td align="left" rowspan="1" colspan="1">ttggaCCGGTGTGTGCAGCGCGAG</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCCTTAGGAGATTGTCAAGGG</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs16829225</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGGATGAAGATTCAGGCTGCTC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">AGGCTGCTCTCCCATCATTTTG</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTCCCTTCATTCACACGAAGC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TNFRSF1B</td><td align="left" rowspan="1" colspan="1">rs235214</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGAAAAGCAAGGTGTTGCCAGG</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TTGCCAGGCCTGCTAGGCTCAAA</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCAAGGAATCAGATTCTCCCC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs496888</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTCTCAAACCCACTGCTTGAC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GCCTGGTCTTAGGACAC</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGATATCCTGACCCCACAGCCT</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs652625</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTCTAGTTGTCCCCCACACAC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACACCTCAAGACCAATGGG</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGATAGGGAAACTGGCAGGAGG</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs7550488</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTCCCAGCCTTTAGATTCACC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CTGCTCAGCCCAACCTCC</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGGGGTAGACATCTTTCTGGG</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TRIP12</td><td align="left" rowspan="1" colspan="1">rs1035833</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTCGCTGTCCTGTTTTTATGC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TCTTCCATTCTTACATGATCT</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGGATGTGTATCTCAGATTACC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IL1RL1</td><td align="left" rowspan="1" colspan="1">rs13431828</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCGTTGTTGAGATTACTCCAG</named-content>
</td><td align="left" rowspan="1" colspan="1">ggAGATGAGTCACTGGCATAC</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGAGAGTATCACCAACTGCCTC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IL1A</td><td align="left" rowspan="1" colspan="1">rs17561</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTCACATTGCTCAGGAAGCTA</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ATTGCTCAGGAAGCTAAAAGGTG</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGATCTGCACTTGTGATCATGG</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs1800587</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTGGGAGAAAGGAAGGCATGG</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GGATTTTTACATATGAGCCTTCAATG</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGGGCCACAGGAATTATAAAAGC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">FAM79B</td><td align="left" rowspan="1" colspan="1">rs13059863</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTGATTGACAGGAGTCATGGG</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GGTGAGTGGTTAAGGATAG</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGACTGGCACTATGTTAAACAC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">LAMA2</td><td align="left" rowspan="1" colspan="1">rs2571584</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTAAATCTGGGCAGTTGAGGG</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CAGTTGAGGGATTGCTTTTAACAGAA</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTAGTATCTATATCCCCTGTC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TNFAIP3</td><td align="left" rowspan="1" colspan="1">rs3757173</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTCAGATGGAAAGAGATGGGC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GGCAGTAGGAAGATTTTAAACAAA</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGAGAGTCAGGCAAGCAAAAAG</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs5029938</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCTCTTGTGAAATGAGGGCAG</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ATGAGGGCAGTAAGTGAT</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGGCCTTCACCAGCAAATCAAG</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">LAMB1</td><td align="left" rowspan="1" colspan="1">rs4727695</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTCCCTACTGTTCCATTTCTC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CCATTTCTCTTTATTTCCATCTC</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTATTCTCACCACTGAGCCAC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MET</td><td align="left" rowspan="1" colspan="1">rs38850</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGGGCTACTACACTTAACCATT</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACACTTAACCATTATGTAACTTC</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCCTGAGATGCAGAAGGTGTT</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">RAC1</td><td align="left" rowspan="1" colspan="1">rs836479</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTGGGTTTGGTTTGTTTCCCG</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CGCCTTCCTCCTTGTGC</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCTGCCACACCAGCAAATGTC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">KIAA1456</td><td align="left" rowspan="1" colspan="1">rs11779957</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCATAATCACAACTTAAAGGC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TTAAAGGCAAAAGTAGTACTC</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGGGCTCTCAGCAGGAAAATAC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MSRA</td><td align="left" rowspan="1" colspan="1">rs7001821</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTGAGTTGATCGATCTAGAGG</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TCTAGAGGTTAATGTATTATAAAGAA</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGACTCACCAGCCTCCATAATC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MUSK</td><td align="left" rowspan="1" colspan="1">rs10817091</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCTATTCAAAACCTATTGTC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TATTTTGCATTATATACTTAATGCT</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTCTGCTAGTATTGAATCCTC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">PDGFD</td><td align="left" rowspan="1" colspan="1">rs12574463</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGAGGAGAGTGATGCCAAACAG</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">AGTTTACATCCAAACTATAGAGG</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGATGGTGCAGTCTCATAACTC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NOS1</td><td align="left" rowspan="1" colspan="1">rs1483757</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCAACTGAGCTGATTCTCTGG</named-content>
</td><td align="left" rowspan="1" colspan="1">ggTGGGGTTGAAATTGACTTCC</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGAAAGGGACACTAGGCAAGAG</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NAV3</td><td align="left" rowspan="1" colspan="1">rs1726427</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGATCTATGACTTGCACAGGAG</named-content>
</td><td align="left" rowspan="1" colspan="1">tCACAGGAGTTGTGTAGC</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGAGCACCTGGCACTTTATTGG</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IRAK4</td><td align="left" rowspan="1" colspan="1">rs4251559</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGGATACAGTTGGTGGTACAGG</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GGTACAGGCAATAAGTAAAACA</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCCTGTTGCCCCTTTCTTTAG</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">SERPINA1</td><td align="left" rowspan="1" colspan="1">rs1243168</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTGCCTGTGAATAATCCAACC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ATAATCCAACCAAGAGCAACACAAA</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGACAGATGACCTCAAACACCC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs4900229</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGAGAACTCCTCACCCAGCAGA</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GGGTTGTGCAGAGAGGCT</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGACGAGAAGCCCTGAGAGTG</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">UBE3A</td><td align="left" rowspan="1" colspan="1">rs1557871</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCCCACACCTGCATCAAAATC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">AATCTTGCAGTGCCTATTAA</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGAGTCCCAAGTCTTTTCTCCC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">SLC13A3</td><td align="left" rowspan="1" colspan="1">rs393990</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTAGGTGGAGCTGCTCTATTC</named-content>
</td><td align="left" rowspan="1" colspan="1">ggaCCAGTGAAAATAATTGTCATG</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGTGTCCTGCATGTGGAGTTTC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CACNA1I</td><td align="left" rowspan="1" colspan="1">rs3788568</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGCTTATGCCTGACATGGCACC</named-content>
</td><td align="left" rowspan="1" colspan="1">gCACTCGGGGGAGATGGAC</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACGTTGGATGGCCTTCAGAACAAAGAGACC</named-content>
</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone-0039247-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0039247.t003</object-id><label>Table 3</label><caption><title>Details of the primers used in the screening of SNPs by PCR resequencing.</title></caption><alternatives><graphic id="pone-0039247-t003-3" xlink:href="pone.0039247.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Gene</td><td align="left" rowspan="1" colspan="1">SNP</td><td align="left" rowspan="1" colspan="1">Primers (forward)</td><td align="left" rowspan="1" colspan="1">Primers (reverse)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">IL1RL1</td><td align="left" rowspan="1" colspan="1">rs10204137</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CCCCTCAGATCACTCACAAT</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">AGCCAGCTAGGAGAAGTCAG</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1">IL1A</td><td align="left" rowspan="1" colspan="1">rs2856838</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TGGGACTGCTATTCTTACAC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CTTTCCAATTAGTTCCCTCT</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs2048874;</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">TGTGGAGGGGCAGTCATA</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACCAACACCAGCAGTATA</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1">RYBP</td><td align="left" rowspan="1" colspan="1">rs4532099</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CTGTGAAGGTGGAAATACTGT</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GAAATGTCAAGAAGTTTACGG</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1">AOAH</td><td align="left" rowspan="1" colspan="1">rs4504543</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CAACATCAGCCTACAGAA</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CTTTCTCCTTTCTTACCA</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1">CACNA2D1</td><td align="left" rowspan="1" colspan="1">rs6972720</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">ACTACTGGTTTCCTTGCTCC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">CCTTCCTTCCAGTACATCTCAA</named-content>
</td></tr><tr><td align="left" rowspan="1" colspan="1">IRAK4</td><td align="left" rowspan="1" colspan="1">rs12302873</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">AATGTGGCATACACCTACC</named-content>
</td><td align="left" rowspan="1" colspan="1">
<named-content content-type="gene">GTTGTGAATAGTTGGAGGC</named-content>
</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="s2d"><title>Determination of Serum total IgE and Allergen-specific IgE</title><p>Serum total and allergen-specific IgE were quantified using Phadiatop test which is based in immunoCap 100 system according to the manufactures&#x02019;s directions (Pharmacia, Uppsala, Sweden). The allergen-specific IgE phadiatop covered all the common aeroallergens which included Dermatophagoides pteronyssinus (Der p); Dermatophagoides farinae (Der f); Animal hair; Trees; Grasses; Cereals; Mugwort; Dandelion; Giant ragweed; Chenopodium album; Humulus; Locust; Blatella germanica; Pine; Plantain; Curvularia lunata; Candida albicans; Penicillium notatum; Alternaria tenuis and Aspergillus fumigatu. The CAP classification system divides results into seven categories from 0 to 6. Additional classes are scored as follows: 0.35&#x02013;0.70 kU/L, class 1; 0.71&#x02013;3.5 kU/L, class 2; 3.51&#x02013;7.5 kU/L, class 3; 7.6&#x02013;17.5 kU/L, class 4; 17.6&#x02013;50 kU/L, class 5; 50 kU/L, class 6. The units reported by CAP are in accordance with the defined WHO serum standard IRP 75/520. For the present analyses, subjects were considered as sensitive to the allergens if the measurement of allergen-specific IgE phadiatop was equal to or above 0.35 kU/L.</p></sec><sec id="s2e"><title>Statistical Analyses</title><p>PLINK program version v1.02 was used to determine association. The association test is based on comparing allele frequencies between cases and controls using Chi-squared tests (&#x003c7;2). We estimated odds ratios (OR) and 95&#x00025; confidence intervals (95&#x00025; CI) for the effect of polymorphisms on CRS risk. A corrected p-value of &#x0003c;0.05 was considered statistically significant. Bonferroni correction over the tested SNPs was performed for multiple adjustments. Subanalysis restricted to the presence of nasal polyps was also performed to examine whether the effect of observed associations within the population differed within the subgroups. Associations between genotype and IgE levels for all patients were assessed using an Anova test, which was performed in the <italic>R</italic> statistics software version 2.3.1. Haploview 4.1 software was used to generate the linkage disequilibrium (LD) plot.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Population Characteristics</title><p>
<xref ref-type="table" rid="pone-0039247-t004">Table 4</xref> provides a summary of the demographic characteristics of the study population. Age and gender were all well-balanced between cases and controls. The cohort of 306 CRSwNP patients had a mean age of 43 years and consisted of slightly more men (58.8&#x00025;) than women (41.2&#x00025;), while the 332 CRSsNP individuals had a mean age of 39 years and also consisted of slightly more men (57.2&#x00025;). For the 315 healthy controls mean age were 36, with 53.7&#x00025; men and 46.3&#x00025; women. 14.1&#x00025; and 17.8&#x00025; individuals were atoptic as demonstrated serum Phadiatop positive results in CRSwNP and CRSsNP cases respectively. All the subjects lived in an urbainised region the north of China and the majority of each study group belonged to Beijing and Hebei.</p><table-wrap id="pone-0039247-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0039247.t004</object-id><label>Table 4</label><caption><title>Demographic characteristics of the study population.</title></caption><alternatives><graphic id="pone-0039247-t004-4" xlink:href="pone.0039247.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Characteristic</td><td align="left" rowspan="1" colspan="1">CRSwNP (n&#x0200a;=&#x0200a;306)</td><td align="left" rowspan="1" colspan="1">P (vs. Controls)</td><td align="left" rowspan="1" colspan="1">CRSsNP (n&#x0200a;=&#x0200a;332)</td><td align="left" rowspan="1" colspan="1">P (vs. Controls)</td><td align="left" rowspan="1" colspan="1">Controls (n&#x0200a;=&#x0200a;315)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age Mean (Range) (years)</td><td align="left" rowspan="1" colspan="1">43&#x000b1;16 (7&#x02013;77)</td><td align="left" rowspan="1" colspan="1">0.0618</td><td align="left" rowspan="1" colspan="1">39&#x000b1;16 (7&#x02013;77)</td><td align="left" rowspan="1" colspan="1">0.0506</td><td align="left" rowspan="1" colspan="1">36&#x000b1;15 (3&#x02013;78)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex, No.(&#x00025;) of Male</td><td align="left" rowspan="1" colspan="1">180 (58.8)</td><td align="left" rowspan="1" colspan="1">0.194</td><td align="left" rowspan="1" colspan="1">190 (57.2)</td><td align="left" rowspan="1" colspan="1">0.360</td><td align="left" rowspan="1" colspan="1">169 (53.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Total IgE, kU/l</td><td align="left" rowspan="1" colspan="1">120.2&#x000b1;211.4</td><td align="left" rowspan="1" colspan="1">0.0006<xref ref-type="table-fn" rid="nt101">&#x0002a;</xref>
</td><td align="left" rowspan="1" colspan="1">112.1&#x000b1;277.1</td><td align="left" rowspan="1" colspan="1">0.0183<xref ref-type="table-fn" rid="nt101">&#x0002a;</xref>
</td><td align="left" rowspan="1" colspan="1">57.4&#x000b1;111.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum phadiatop &#x0002b;, No.(&#x00025;)</td><td align="left" rowspan="1" colspan="1">43 (14.1)</td><td align="left" rowspan="1" colspan="1">0.200<xref ref-type="table-fn" rid="nt102">#</xref>
</td><td align="left" rowspan="1" colspan="1">59 (17.8)</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Living city, No.(&#x00025;)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Beijing</td><td align="left" rowspan="1" colspan="1">217 (70.9)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">233 (70.2)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">146 (57.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hebei</td><td align="left" rowspan="1" colspan="1">25 (8.2)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">29 (8.7)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">19 (19.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Others</td><td align="left" rowspan="1" colspan="1">64 (20.9)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">70 (21.1)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">46 (23.8)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label>&#x0002a;</label><p>: P value &#x0003c;0.05</p></fn><fn id="nt102"><label>#</label><p>: P-value regarding to serum phadiatop between CRSwNP and CRSsNP subjects.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Association Analysis</title><p>Allele frequencies for all 49 SNPs were calculated and the significant associations between alleles and CRS phenotype were shown in <xref ref-type="table" rid="pone-0039247-t005">Table 5</xref>. The significant associations (P<sub>&#x0003c;</sub>0.05) only existed among the genes coding RYBP (rs4532099), AOAH (rs4504543) and IRAK4 (rs1461567, rs4251559 and rs3794262) genes at 5 loci. <xref ref-type="table" rid="pone-0039247-t005">Table 5</xref> shows odds ratios for risk allele and the corresponding P values. Two SNPs respectively in RYBP (rs4532099, P&#x0200a;=&#x0200a;2.15E&#x02013;06, OR&#x0200a;=&#x0200a;2.59) and AOAH (rs4504543, P&#x0200a;=&#x0200a;0.0001152, OR&#x0200a;=&#x0200a;0.58) remained significant following application of the Bonferroni correction for multiple testing for 49 simultaneous tests (P&#x0003c;0.001).</p><p>As for the subgroup analysis for the presence of nasal polyps (CRSwNP and CRSsNP) displayed significant association in CRSwNP cohorts regarding to one SNP in RYBP (rs4532099) and 5 SNPs IRAK4 (rs4252431, 6582484, rs1461567, rs4251559 and rs3794262) (<xref ref-type="table" rid="pone-0039247-t006">Table 6</xref>). Among the six SNPs, only rs4532099 in RYBP (P&#x0200a;=&#x0200a;3.24E&#x02013;006, OR&#x0200a;=&#x0200a;2.76) remained significant following application of the Bonferroni multiple testing (P&#x0003c;0.001). Likewise, we detected evidence of association in the CRSsNP subgroups in terms of 4 SNPs (AOAH_rs4504543, RYBP_rs4532099, IRAK4_rs1461567 and IL1RL1_rs13431828) as well (<xref ref-type="table" rid="pone-0039247-t006">Table 6</xref>), while only rs4504543 in AOAH (P&#x0200a;=&#x0200a;8.11E&#x02013;011, OR&#x0200a;=&#x0200a;0.30) and rs4532099 in RYBP (P&#x0200a;=&#x0200a;4.12E&#x02013;005, OR&#x0200a;=&#x0200a;2.45) remained significant following application of the multiple adjustment (P&#x0003c;0.001).</p><p>In order to verify potential association between total serum IgE levels and the selected SNPs, a quantitative trait analysis was performed. As presented in <xref ref-type="table" rid="pone-0039247-t007">Table 7</xref>, <xref ref-type="table" rid="pone-0039247-t003">3</xref> SNPs (IL1A_rs17561, P&#x0200a;=&#x0200a;0.005778; IL1A_rs1800587, P&#x0200a;=&#x0200a;0.009561; IRAK4_rs4251513, P&#x0200a;=&#x0200a;0.03837) were associated with serum total IgE level.</p><table-wrap id="pone-0039247-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0039247.t005</object-id><label>Table 5</label><caption><title>Single nucleotide polymorphisms associated with chronic rhinosinusitis.</title></caption><alternatives><graphic id="pone-0039247-t005-5" xlink:href="pone.0039247.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">SNP</td><td align="left" rowspan="1" colspan="1">Associate allele</td><td align="left" rowspan="1" colspan="1">Case; Control Frequencies</td><td align="left" rowspan="1" colspan="1">Chi squared</td><td align="left" rowspan="1" colspan="1">OR</td><td align="left" rowspan="1" colspan="1">P</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">RYBP_rs4532099</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.14; 0.06</td><td align="left" rowspan="1" colspan="1">22.46</td><td align="left" rowspan="1" colspan="1">2.59</td><td align="left" rowspan="1" colspan="1">2.15&#x000d7;10<sup>&#x02212;6</sup>
<xref ref-type="table-fn" rid="nt104">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">AOAH_rs4504543</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">0.13; 0.21</td><td align="left" rowspan="1" colspan="1">14.87</td><td align="left" rowspan="1" colspan="1">0.58</td><td align="left" rowspan="1" colspan="1">0.0001152<xref ref-type="table-fn" rid="nt104">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">IRAK4_rs1461567</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">0.48; 0.54</td><td align="left" rowspan="1" colspan="1">5.36</td><td align="left" rowspan="1" colspan="1">0.79</td><td align="left" rowspan="1" colspan="1">0.0206</td></tr><tr><td align="left" rowspan="1" colspan="1">IRAK4_rs4251559</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.45; 0.51</td><td align="left" rowspan="1" colspan="1">5.331</td><td align="left" rowspan="1" colspan="1">0.79</td><td align="left" rowspan="1" colspan="1">0.02095</td></tr><tr><td align="left" rowspan="1" colspan="1">IRAK4_rs3794262</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">0.14; 0.18</td><td align="left" rowspan="1" colspan="1">4.998</td><td align="left" rowspan="1" colspan="1">0.73</td><td align="left" rowspan="1" colspan="1">0.02538</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label/><p>SNP: Single nucleotide polymorphisms; OR: Odd ratio; P: p-value.</p></fn><fn id="nt104"><label>&#x0002a;</label><p>: P value remains significant after Bonferroni correction.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0039247-t006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0039247.t006</object-id><label>Table 6</label><caption><title>Single nucleotide polymorphisms associated with subgroups of CRSwNP and CRSsNP.</title></caption><alternatives><graphic id="pone-0039247-t006-6" xlink:href="pone.0039247.t006"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">SNP</td><td align="left" rowspan="1" colspan="1">Associate allele</td><td colspan="4" align="left" rowspan="1">CRSwNP</td><td colspan="4" align="left" rowspan="1">CRSsNP</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Case; Control Frequencies</td><td align="left" rowspan="1" colspan="1">Chi squared</td><td align="left" rowspan="1" colspan="1">OR</td><td align="left" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1">Case; Control Frequencies</td><td align="left" rowspan="1" colspan="1">Chi squared</td><td align="left" rowspan="1" colspan="1">OR</td><td align="left" rowspan="1" colspan="1">P</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">RYBP_rs4532099</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.15; 0.06</td><td align="left" rowspan="1" colspan="1">21.67</td><td align="left" rowspan="1" colspan="1">2.76</td><td align="left" rowspan="1" colspan="1">3.24&#x000d7;10<sup>&#x02212;6</sup>
<xref ref-type="table-fn" rid="nt106">&#x0002a;</xref>
</td><td align="left" rowspan="1" colspan="1">0.13; 0.06</td><td align="left" rowspan="1" colspan="1">16.82</td><td align="left" rowspan="1" colspan="1">2.45</td><td align="left" rowspan="1" colspan="1">4.12&#x000d7;10<sup>&#x02212;5</sup>
<xref ref-type="table-fn" rid="nt106">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">IRAK4_rs4251431</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">0.07; 0.11</td><td align="left" rowspan="1" colspan="1">6.07</td><td align="left" rowspan="1" colspan="1">0.60</td><td align="left" rowspan="1" colspan="1">0.01375</td><td align="left" rowspan="1" colspan="1">0.09; 0.06</td><td align="left" rowspan="1" colspan="1">0.94</td><td align="left" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="1" colspan="1">0.3313</td></tr><tr><td align="left" rowspan="1" colspan="1">IRAK4_rs6582484</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">0.09; 0.13</td><td align="left" rowspan="1" colspan="1">5.154</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">0.02319</td><td align="left" rowspan="1" colspan="1">0.10; 0.13</td><td align="left" rowspan="1" colspan="1">0.70</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">0.4039</td></tr><tr><td align="left" rowspan="1" colspan="1">IRAK4_rs1461567</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">0.48; 0.54</td><td align="left" rowspan="1" colspan="1">4.284</td><td align="left" rowspan="1" colspan="1">0.79</td><td align="left" rowspan="1" colspan="1">0.03848</td><td align="left" rowspan="1" colspan="1">0.48; 0.54</td><td align="left" rowspan="1" colspan="1">4.453</td><td align="left" rowspan="1" colspan="1">0.79</td><td align="left" rowspan="1" colspan="1">0.03484</td></tr><tr><td align="left" rowspan="1" colspan="1">IRAK4_rs3794262</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">0.13; 0.18</td><td align="left" rowspan="1" colspan="1">4.157</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">0.04145</td><td align="left" rowspan="1" colspan="1">0.14; 0.18</td><td align="left" rowspan="1" colspan="1">2.05</td><td align="left" rowspan="1" colspan="1">0.89</td><td align="left" rowspan="1" colspan="1">0.1523</td></tr><tr><td align="left" rowspan="1" colspan="1">IRAK4_rs4251559</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.45; 0.51</td><td align="left" rowspan="1" colspan="1">3.852</td><td align="left" rowspan="1" colspan="1">0.79</td><td align="left" rowspan="1" colspan="1">0.04968</td><td align="left" rowspan="1" colspan="1">0.45; 0.51</td><td align="left" rowspan="1" colspan="1">2.86</td><td align="left" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="1" colspan="1">0.0911</td></tr><tr><td align="left" rowspan="1" colspan="1">AOAH_rs4504543</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">0.20; 0.21</td><td align="left" rowspan="1" colspan="1">0.22</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.6371</td><td align="left" rowspan="1" colspan="1">0.07; 0.21</td><td align="left" rowspan="1" colspan="1">42.23</td><td align="left" rowspan="1" colspan="1">0.30</td><td align="left" rowspan="1" colspan="1">8.11&#x000d7;10<sup>&#x02212;11</sup>
<xref ref-type="table-fn" rid="nt106">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">IL1RL1_rs13431828</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">0.10; 0.11</td><td align="left" rowspan="1" colspan="1">0.74</td><td align="left" rowspan="1" colspan="1">0.92</td><td align="left" rowspan="1" colspan="1">0.3887</td><td align="left" rowspan="1" colspan="1">0.07; 0.11</td><td align="left" rowspan="1" colspan="1">4.032</td><td align="left" rowspan="1" colspan="1">0.64</td><td align="left" rowspan="1" colspan="1">0.04464</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt105"><label/><p>SNP: Single nucleotide polymorphisms; OR: Odd ratio; P: p-value.</p></fn><fn id="nt106"><label>&#x0002a;</label><p>: P value remains significant after Bonferroni correction.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0039247-t007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0039247.t007</object-id><label>Table 7</label><caption><title>Association between polymorphisms and IgE levels.</title></caption><alternatives><graphic id="pone-0039247-t007-7" xlink:href="pone.0039247.t007"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">SNP</td><td align="left" rowspan="1" colspan="1">BETA</td><td align="left" rowspan="1" colspan="1">SE</td><td align="left" rowspan="1" colspan="1">R2</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">P</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">IL1A_rs17561</td><td align="left" rowspan="1" colspan="1">58.15</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">0.01112</td><td align="left" rowspan="1" colspan="1">2.769</td><td align="left" rowspan="1" colspan="1">0.005778</td></tr><tr><td align="left" rowspan="1" colspan="1">IL1A_rs1800587</td><td align="left" rowspan="1" colspan="1">54.14</td><td align="left" rowspan="1" colspan="1">20.84</td><td align="left" rowspan="1" colspan="1">0.009762</td><td align="left" rowspan="1" colspan="1">2.599</td><td align="left" rowspan="1" colspan="1">0.009561</td></tr><tr><td align="left" rowspan="1" colspan="1">IRAK4_rs4251513</td><td align="left" rowspan="1" colspan="1">31.54</td><td align="left" rowspan="1" colspan="1">15.21</td><td align="left" rowspan="1" colspan="1">0.004459</td><td align="left" rowspan="1" colspan="1">2.074</td><td align="left" rowspan="1" colspan="1">0.03837</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt107"><label/><p>BETA: regression coefficient; SE: standard error; R2: regression r-squared; T: Wald test (based on t-distribtion); P: p-value.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s4"><title>Discussion</title><p>In this study, we replicate a number of genes in CRS in previously identified in Caucasians in a Han Chinese population. Genes associated with CRS and the Caucasian population has not yet being replicated in the Chinese population and the replication suggests a common basis.</p><p>The genes identified are of potential important biological significance. RYBP is a regulator of transcription <xref rid="pone.0039247-Bejarano1" ref-type="bibr">[12]</xref>. ILIRL1 is associated with Toll-like receptor (TLR) signaling regulation <xref rid="pone.0039247-Savenije1" ref-type="bibr">[14]</xref>. SNPs in the IL1RL1 gene have previously been shown to affect serum level of eosinophilia and IgE in other models <xref rid="pone.0039247-Castano2" ref-type="bibr">[5]</xref>. IRAK4 also is implicated as a signaling intermediate in the TLR signaling pathway <xref rid="pone.0039247-Bosse1" ref-type="bibr">[16]</xref>, <xref rid="pone.0039247-Suzuki1" ref-type="bibr">[22]</xref>, and SNPs in the IRAK4 gene have been documented to have a functional impact, within genotype specific effect on serum IgE level <xref rid="pone.0039247-Tewfik2" ref-type="bibr">[6]</xref>, <xref rid="pone.0039247-Zhang2" ref-type="bibr">[23]</xref>.</p><p>Importance of TLR signaling is suggested by their role in detecting and regulating responses to gram-positive and gram-negative bacteria. Importance of IRAK-4 is suggested by the description of an enhanced susceptibility to infection with gram-positive bacteria in IRAK-4 deficient children. Previous work from the Desrosiers group has identified altered function of the TLR signaling system as key to the pathogenesis of CRS. Using complex-model analysis of pooling-based genome wide association testing on the Canadian population with CRS, they identified the polymorphisms at multiple levels of the TLR signaling cascade all confer an increased risk in CRS <xref rid="pone.0039247-MfunaEndam1" ref-type="bibr">[2]</xref>, <xref rid="pone.0039247-Bosse1" ref-type="bibr">[16]</xref>. Functional support for this concept has been provided by in vitro model of epithelial cell culture documenting reduced response to TLR agonists in epithelial cells from CRS patients <xref rid="pone.0039247-C1" ref-type="bibr">[24]</xref>.</p><p>The identification of the AOAH gene is also of potential significant interest and suggests a novel mechanism for the development of CRS, again implicating an innate immune signaling, but in a novel fashion. AOAH is responsible for degrading lipopolysaccharide (LPS), and dysfunctional AOAH gene function leads to decreased LPS degradation with unopposed continued LPS stimulation via a TLR-4 dependant mechanism. In AOAH knockout mouse models, persistent inflammation following LPS stimulation is observed <xref rid="pone.0039247-Shao1" ref-type="bibr">[25]</xref>&#x02013;<xref rid="pone.0039247-Lu1" ref-type="bibr">[27]</xref>. Supporting a role in airway disease, the AOAH gene has previously been implicated in a genome wide scan for asthma <xref rid="pone.0039247-Barnes1" ref-type="bibr">[13]</xref>. Corresponding to the above literature, here we presented that rs4504543 in the AOAH gene played a protective role (OR&#x0200a;=&#x0200a;0.58) in CRS with a strong P value (P&#x0200a;=&#x0200a;0.0001152). Moreover, the AOAH_ rs4504543 loci was also revealed as a protective factor (OR&#x0200a;=&#x0200a;0.30) in CRSsNP group with a stronger P value (P&#x0200a;=&#x0200a;8.11&#x02013;011), indicating that AOAH gene might exert a crucial protective role in the development of CRS.</p><p>RYBP is a zinc finger protein with an essential role during embryonic development, which binds transcriptional factors, polycomb products, and mediators of apoptosis, suggesting roles in apparently,unrelated functions. Gene products of the RYBP gene inhibit ubiquitination and subsequent degradation of TP53, and, by interacting with MDM2, play a role in regulating transcription of TP53 target genes and promoting apoptosis. Recent findings have also suggested that RYBP may also play a role in epigenetic regulation <xref rid="pone.0039247-Tavares1" ref-type="bibr">[28]</xref>, and contribute to defense against retroviruses <xref rid="pone.0039247-Hisada1" ref-type="bibr">[29]</xref>. It is thus possible that polymorphisms in the RYBP gene may be implicated in CRS by dysregulating TP53 activity in TP53 or in its target genes via alteration of RYBP gene products or by altering binding at regulatory binding sites in the RYBP gene promotor area, which contains binding sites for the following transcription factors (YY1, IRF-1, C/EBPA, GATA-1, POU2F1). This may contribute to the inflammation observed in CRS, promoting epithelial dysfunction with secondary bacterial colonization. In contrast to AOAH gene, polymorphisms in the RYBP gene was exhibited here for the first time as a significantly risk factor of CRS and either of the subgroups (CRSsNP and CRSwNP) with high OR values (OR<sub>CRS</sub>&#x0200a;=&#x0200a;2.59; OR<sub>CRSsNP</sub>&#x0200a;=&#x0200a;2.76; OR<sub>CRSwNP</sub>&#x0200a;=&#x0200a;2.45), suggesting the variation of rs4532099 in RYBP could increase the risk of CRS development.</p><p>IL1RL1 gene is involved in regulation of TLR signaling and has recently also been implicated as the receptor for IL-33. Its role in development of CRS may be via interfering with TLR signaling, or via an alteration of IL-33 homeostasis.</p><p>Taken overall, all of the replicated genes have disparate functions, but evidence supports that dysfunctions in each these genes may conceivably contribute to development of CRS, underlining the concept that CRS represents a common morphological appearance of clinical disease as an endpoint of multiple unique pathogenic mechasnisms.</p><p>Our study has obvious limitations. First and most noticeable is the small group size of the sample used. Nevertheless, given the limited number of genes genotyped in this replication study, feet corrected P value remains significant and, in the case of the RYBP and AOAH genes, is highly significant with a high odds ratio. A second consideration is the ethnic variability in SNP frequency known for these genes. It is clear that in this study, we have replicated SNPs associated in a Caucasian population, and have not performed extensive fine mapping studies of the gene which might identify other risk SNPs. As shown in this example however, when gene coverage is adjusted to better reflect tagging SNP selection for the CHB data set, we are able to identify significant polymorphisms within the IRAK4 gene.</p><p>We replicate several genes which were proved to be associated with CRS in Caucasian population in a Chinese population, suggesting a common basis to the development of the disease in both population types. Of interest is the potential implication of inflammatory pathways, suggesting dysfunction in TLR signaling as a critical element in chronic rhinosinusitis. While these studies have significant limitations, they nevertheless offer a basis for further exploration of a role for immune signaling and response to bacteria in further studies of CRS.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors declare that co-author Luo Zhang is a PLoS ONE Editorial Board member. This does not alter the authors&#x02019; adherence to all the PLoS ONE policies on sharing data and materials. All other authors declare that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported by grants from the National Science Fund for Distinguished Young Scholars (81025007), the National Natural Science Foundation of China (30973282 and 81100706), the Beijing Natural Science Foundation (7102030), the Special Fund of Sanitation Elite Reconstruction of Beijing (2009-2-007), and Beijing Nova Program (2010B022) to LZ and YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="pone.0039247-Tewfik1"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tewfik</surname><given-names>MA</given-names></name><name><surname>Bosse</surname><given-names>Y</given-names></name><name><surname>Al-Shemari</surname><given-names>H</given-names></name><name><surname>Desrosiers</surname><given-names>M</given-names></name></person-group>
<year>2010</year>
<article-title>Genetics of chronic rhinosinusitis: a primer.</article-title>
<source>J Otolaryngol Head Neck Surg</source>
<volume>39</volume>
<fpage>62</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="pmid">20122347</pub-id></element-citation></ref><ref id="pone.0039247-MfunaEndam1"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mfuna-Endam</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Desrosiers</surname><given-names>MY</given-names></name></person-group>
<year>2011</year>
<article-title>Genetics of rhinosinusitis.</article-title>
<source>Curr Allergy Asthma Rep</source>
<volume>11</volume>
<fpage>236</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="pmid">21499907</pub-id></element-citation></ref><ref id="pone.0039247-Castano1"><label>3</label><element-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Castano</surname><given-names>R</given-names></name><name><surname>Bosse</surname><given-names>Y</given-names></name><name><surname>Endam</surname><given-names>LM</given-names></name><name><surname>Filali-Mouhim</surname><given-names>A</given-names></name><name><surname>Desrosiers</surname><given-names>M</given-names></name></person-group>
<year>2010</year>
<article-title>c-MET pathway involvement in chronic rhinosinusitis: a genetic association analysis.</article-title>
<source>Otolaryngol Head Neck Surg 142: 665&#x02013;671 e661&#x02013;662</source>
</element-citation></ref><ref id="pone.0039247-Tournas1"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tournas</surname><given-names>A</given-names></name><name><surname>Mfuna</surname><given-names>L</given-names></name><name><surname>Bosse</surname><given-names>Y</given-names></name><name><surname>Filali-Mouhim</surname><given-names>A</given-names></name><name><surname>Grenier</surname><given-names>JP</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>A pooling-based genome-wide association study implicates the p73 gene in chronic rhinosinusitis.</article-title>
<source>J Otolaryngol Head Neck Surg</source>
<volume>39</volume>
<fpage>188</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="pmid">20211107</pub-id></element-citation></ref><ref id="pone.0039247-Castano2"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Castano</surname><given-names>R</given-names></name><name><surname>Bosse</surname><given-names>Y</given-names></name><name><surname>Endam</surname><given-names>LM</given-names></name><name><surname>Desrosiers</surname><given-names>M</given-names></name></person-group>
<year>2009</year>
<article-title>Evidence of association of interleukin-1 receptor-like 1 gene polymorphisms with chronic rhinosinusitis.</article-title>
<source>Am J Rhinol Allergy</source>
<volume>23</volume>
<fpage>377</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="pmid">19671251</pub-id></element-citation></ref><ref id="pone.0039247-Tewfik2"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tewfik</surname><given-names>MA</given-names></name><name><surname>Bosse</surname><given-names>Y</given-names></name><name><surname>Lemire</surname><given-names>M</given-names></name><name><surname>Hudson</surname><given-names>TJ</given-names></name><name><surname>Vallee-Smejda</surname><given-names>S</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Polymorphisms in interleukin-1 receptor-associated kinase 4 are associated with total serum IgE.</article-title>
<source>Allergy</source>
<volume>64</volume>
<fpage>746</fpage>
<lpage>753</lpage>
<pub-id pub-id-type="pmid">19254290</pub-id></element-citation></ref><ref id="pone.0039247-MfunaEndam2"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mfuna Endam</surname><given-names>L</given-names></name><name><surname>Cormier</surname><given-names>C</given-names></name><name><surname>Bosse</surname><given-names>Y</given-names></name><name><surname>Filali-Mouhim</surname><given-names>A</given-names></name><name><surname>Desrosiers</surname><given-names>M</given-names></name></person-group>
<year>2010</year>
<article-title>Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: A replication study.</article-title>
<source>Arch Otolaryngol Head Neck Surg</source>
<volume>136</volume>
<fpage>187</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="pmid">20157068</pub-id></element-citation></ref><ref id="pone.0039247-Nader1"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nader</surname><given-names>ME</given-names></name><name><surname>Abou-Jaoude</surname><given-names>P</given-names></name><name><surname>Cabaluna</surname><given-names>M</given-names></name><name><surname>Desrosiers</surname><given-names>M</given-names></name></person-group>
<year>2010</year>
<article-title>Using Response to a Standardized Treatment to Identify Phenotypes for Genetic Studies of Chronic Rhinosinusitis.</article-title>
<source>Journal of Otolaryngology-Head &#x00026; Neck Surgery</source>
<volume>39</volume>
<fpage>69</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">20122348</pub-id></element-citation></ref><ref id="pone.0039247-Kilty1"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kilty</surname><given-names>SJ</given-names></name><name><surname>Bosse</surname><given-names>Y</given-names></name><name><surname>Cormier</surname><given-names>C</given-names></name><name><surname>Endam</surname><given-names>LM</given-names></name><name><surname>Desrosiers</surname><given-names>MY</given-names></name></person-group>
<year>2010</year>
<article-title>Polymorphisms in the SERPINA1 (Alpha-1-Antitrypsin) gene are associated with severe chronic rhinosinusitis unresponsive to medical therapy.</article-title>
<source>Am J Rhinol Allergy</source>
<volume>24</volume>
<fpage>e4</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">20109307</pub-id></element-citation></ref><ref id="pone.0039247-Zhang1"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Endam</surname><given-names>LM</given-names></name><name><surname>Filali-Mouhim</surname><given-names>A</given-names></name><name><surname>Bosse</surname><given-names>Y</given-names></name><name><surname>Castano</surname><given-names>R</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Polymorphisms in the nitric oxide synthase 1 gene are associated with severe chronic rhinosinusitis.</article-title>
<source>Am J Rhinol Allergy</source>
<volume>25</volume>
<fpage>e49</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">21679499</pub-id></element-citation></ref><ref id="pone.0039247-Lee1"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>L</given-names></name><name><surname>Campagna</surname><given-names>DR</given-names></name><name><surname>Pinkus</surname><given-names>JL</given-names></name><name><surname>Mulhern</surname><given-names>H</given-names></name><name><surname>Wyatt</surname><given-names>TA</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Primary ciliary dyskinesia in mice lacking the novel ciliary protein Pcdp1.</article-title>
<source>Mol Cell Biol</source>
<volume>28</volume>
<fpage>949</fpage>
<lpage>957</lpage>
<pub-id pub-id-type="pmid">18039845</pub-id></element-citation></ref><ref id="pone.0039247-Bejarano1"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bejarano</surname><given-names>F</given-names></name><name><surname>Gonzalez</surname><given-names>I</given-names></name><name><surname>Vidal</surname><given-names>M</given-names></name><name><surname>Busturia</surname><given-names>A</given-names></name></person-group>
<year>2005</year>
<article-title>The Drosophila RYBP gene functions as a Polycomb-dependent transcriptional repressor.</article-title>
<source>Mech Dev</source>
<volume>122</volume>
<fpage>1118</fpage>
<lpage>1129</lpage>
<pub-id pub-id-type="pmid">16125914</pub-id></element-citation></ref><ref id="pone.0039247-Barnes1"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barnes</surname><given-names>KC</given-names></name><name><surname>Grant</surname><given-names>A</given-names></name><name><surname>Gao</surname><given-names>P</given-names></name><name><surname>Baltadjieva</surname><given-names>D</given-names></name><name><surname>Berg</surname><given-names>T</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes.</article-title>
<source>J Allergy Clin Immunol</source>
<volume>118</volume>
<fpage>70</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="pmid">16815140</pub-id></element-citation></ref><ref id="pone.0039247-Savenije1"><label>14</label><element-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Savenije</surname><given-names>OE</given-names></name><name><surname>Kerkhof</surname><given-names>M</given-names></name><name><surname>Reijmerink</surname><given-names>NE</given-names></name><name><surname>Brunekreef</surname><given-names>B</given-names></name><name><surname>de Jongste</surname><given-names>JC</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Interleukin-1 receptor-like 1 polymorphisms are associated with serum IL1RL1-a, eosinophils, and asthma in childhood.</article-title>
<source>J Allergy Clin Immunol 127: 750&#x02013;756 e751&#x02013;755</source>
</element-citation></ref><ref id="pone.0039247-Kim1"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>TW</given-names></name><name><surname>Staschke</surname><given-names>K</given-names></name><name><surname>Bulek</surname><given-names>K</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Peters</surname><given-names>K</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.</article-title>
<source>J Exp Med</source>
<volume>204</volume>
<fpage>1025</fpage>
<lpage>1036</lpage>
<pub-id pub-id-type="pmid">17470642</pub-id></element-citation></ref><ref id="pone.0039247-Bosse1"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bosse</surname><given-names>Y</given-names></name><name><surname>Bacot</surname><given-names>F</given-names></name><name><surname>Montpetit</surname><given-names>A</given-names></name><name><surname>Rung</surname><given-names>J</given-names></name><name><surname>Qu</surname><given-names>HQ</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Identification of susceptibility genes for complex diseases using pooling-based genome-wide association scans.</article-title>
<source>Hum Genet</source>
<volume>125</volume>
<fpage>305</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="pmid">19184112</pub-id></element-citation></ref><ref id="pone.0039247-Meltzer1"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meltzer</surname><given-names>EO</given-names></name><name><surname>Hamilos</surname><given-names>DL</given-names></name><name><surname>Hadley</surname><given-names>JA</given-names></name><name><surname>Lanza</surname><given-names>DC</given-names></name><name><surname>Marple</surname><given-names>BF</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Rhinosinusitis: Establishing definitions for clinical research and patient care.</article-title>
<source>Otolaryngol Head Neck Surg</source>
<volume>131</volume>
<fpage>S1</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">15577816</pub-id></element-citation></ref><ref id="pone.0039247-Endam1"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Endam</surname><given-names>LM</given-names></name><name><surname>Bosse</surname><given-names>Y</given-names></name><name><surname>Filali-Mouhim</surname><given-names>A</given-names></name><name><surname>Cormier</surname><given-names>C</given-names></name><name><surname>Boisvert</surname><given-names>P</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Polymorphisms in the interleukin-22 receptor alpha-1 gene are associated with severe chronic rhinosinusitis.</article-title>
<source>Otolaryngol Head Neck Surg</source>
<volume>140</volume>
<fpage>741</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="pmid">19393422</pub-id></element-citation></ref><ref id="pone.0039247-Cormier1"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cormier</surname><given-names>C</given-names></name><name><surname>Bosse</surname><given-names>Y</given-names></name><name><surname>Mfuna</surname><given-names>L</given-names></name><name><surname>Hudson</surname><given-names>TJ</given-names></name><name><surname>Desrosiers</surname><given-names>M</given-names></name></person-group>
<year>2009</year>
<article-title>Polymorphisms in the tumour necrosis factor alpha-induced protein 3 (TNFAIP3) gene are associated with chronic rhinosinusitis.</article-title>
<source>J Otolaryngol Head Neck Surg</source>
<volume>38</volume>
<fpage>133</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">19344623</pub-id></element-citation></ref><ref id="pone.0039247-1"><label>20</label><element-citation publication-type="journal">
<year>2005</year>
<article-title>A haplotype map of the human genome.</article-title>
<source>Nature</source>
<volume>437</volume>
<fpage>1299</fpage>
<lpage>1320</lpage>
<pub-id pub-id-type="pmid">16255080</pub-id></element-citation></ref><ref id="pone.0039247-Barrett1"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group>
<year>2005</year>
<article-title>Haploview: analysis and visualization of LD and haplotype maps.</article-title>
<source>Bioinformatics</source>
<volume>21</volume>
<fpage>263</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="pmid">15297300</pub-id></element-citation></ref><ref id="pone.0039247-Suzuki1"><label>22</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>N</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group>
<year>2006</year>
<article-title>IRAK-4&#x02013;a shared NF-kappaB activator in innate and acquired immunity.</article-title>
<source>Trends Immunol</source>
<volume>27</volume>
<fpage>566</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="pmid">17046325</pub-id></element-citation></ref><ref id="pone.0039247-Zhang2"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Desrosiers</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Meng</surname><given-names>N</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Association pattern of interleukin-1 receptor-associated kinase-4 gene polymorphisms with allergic rhinitis in a Han Chinese population.</article-title>
<source>PLoS One</source>
<volume>6</volume>
<fpage>e21769</fpage>
<pub-id pub-id-type="pmid">21738793</pub-id></element-citation></ref><ref id="pone.0039247-C1"><label>24</label><element-citation publication-type="other">
<person-group person-group-type="author"><name><surname>C</surname><given-names>Divoy</given-names></name><name><surname>S</surname><given-names>Rousseau</given-names></name><name><surname>J</surname><given-names>Berube</given-names></name><name><surname>L. Mfuna</surname><given-names>Endam</given-names></name><name><surname>A</surname><given-names>Filali-Mouhim</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Epithelial Cells From Chronic Rhinosinusitis Patients Are Hyporesponsive To Bacteria: Evidence Of Innate Immune Dysfunction In CRS.</article-title>
<source>J Allergy Clin Immunol</source>
<fpage>AB2</fpage>
<lpage>AB3</lpage>
</element-citation></ref><ref id="pone.0039247-Shao1"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shao</surname><given-names>B</given-names></name><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Katz</surname><given-names>SC</given-names></name><name><surname>Varley</surname><given-names>AW</given-names></name><name><surname>Hardwick</surname><given-names>J</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen.</article-title>
<source>J Biol Chem</source>
<volume>282</volume>
<fpage>13726</fpage>
<lpage>13735</lpage>
<pub-id pub-id-type="pmid">17322564</pub-id></element-citation></ref><ref id="pone.0039247-Ojogun1"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ojogun</surname><given-names>N</given-names></name><name><surname>Kuang</surname><given-names>TY</given-names></name><name><surname>Shao</surname><given-names>B</given-names></name><name><surname>Greaves</surname><given-names>DR</given-names></name><name><surname>Munford</surname><given-names>RS</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Overproduction of acyloxyacyl hydrolase by macrophages and dendritic cells prevents prolonged reactions to bacterial lipopolysaccharide in vivo.</article-title>
<source>J Infect Dis</source>
<volume>200</volume>
<fpage>1685</fpage>
<lpage>1693</lpage>
<pub-id pub-id-type="pmid">19860560</pub-id></element-citation></ref><ref id="pone.0039247-Lu1"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Varley</surname><given-names>AW</given-names></name><name><surname>Ohta</surname><given-names>S</given-names></name><name><surname>Hardwick</surname><given-names>J</given-names></name><name><surname>Munford</surname><given-names>RS</given-names></name></person-group>
<year>2008</year>
<article-title>Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection.</article-title>
<source>Cell Host Microbe</source>
<volume>4</volume>
<fpage>293</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="pmid">18779055</pub-id></element-citation></ref><ref id="pone.0039247-Tavares1"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tavares</surname><given-names>L</given-names></name><name><surname>Dimitrova</surname><given-names>E</given-names></name><name><surname>Oxley</surname><given-names>D</given-names></name><name><surname>Webster</surname><given-names>J</given-names></name><name><surname>Poot</surname><given-names>R</given-names></name><etal/></person-group>
<year>2012</year>
<article-title>RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3.</article-title>
<source>Cell</source>
<volume>148</volume>
<fpage>664</fpage>
<lpage>678</lpage>
<pub-id pub-id-type="pmid">22325148</pub-id></element-citation></ref><ref id="pone.0039247-Hisada1"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hisada</surname><given-names>K</given-names></name><name><surname>Sanchez</surname><given-names>C</given-names></name><name><surname>Endo</surname><given-names>TA</given-names></name><name><surname>Endoh</surname><given-names>M</given-names></name><name><surname>Roman-Trufero</surname><given-names>M</given-names></name><etal/></person-group>
<year>2012</year>
<article-title>RYBP represses endogenous retroviruses and preimplantation- and germ line-specific genes in mouse embryonic stem cells.</article-title>
<source>Mol Cell Biol</source>
<volume>32</volume>
<fpage>1139</fpage>
<lpage>1149</lpage>
<pub-id pub-id-type="pmid">22269950</pub-id></element-citation></ref></ref-list></back></article>